T. Rowe Price Associates
BTMD icon

T. Rowe Price Associates’s Biote Corp BTMD Stock Holding History

T. Rowe Price Associates’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,822
Closed -$21K – 3250
2026
Q1 		$21K Hold
14,822
– – ﹤0.01% 3117
2025
Q4 		$39K Hold
14,822
– – ﹤0.01% 3058
2025
Q3 		$45K Hold
14,822
– – ﹤0.01% 3017
2025
Q2 		$60K Buy
14,822
+4,113
+38% +$15.2K ﹤0.01% 2982
2025
Q1 		$36K Hold
10,709
– – ﹤0.01% 2963
2024
Q4 		$67K Buy
+10,709
New +$62.2K ﹤0.01% 2895

Other funds holding BTMD

3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BP
Bandera Partners New York $284M AUM 33.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates's BTMD Position: Q2 2026 in Review

T. Rowe Price Associates sold out of Biote Corp (BTMD) in Q2 2026, closing a stake of 14,822 shares — an estimated $21K sold.

T. Rowe Price Associates first reported a position in BTMD in Q4 2024 and held it in 6 quarters. The position peaked at $67K in Q4 2024. 71 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

  • T. Rowe Price Associates reported no remaining Biote Corp position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 14,822 Biote Corp shares in Q2 2026, an estimated $21K.
  • T. Rowe Price Associates first reported a position in Biote Corp in Q4 2024 and held it in 6 quarters.
  • T. Rowe Price Associates's Biote Corp position peaked at $67K in Q4 2024.
  • 71 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.